Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech Valuation -- Ignore unavailable to you. Want to Upgrade?

To: Biomaven who wrote (3813)	5/17/2001 3:38:09 PM
From: Biomaven	Read Replies (2) \| Respond to of 52153

Had a brief chat with a friend of mine who is a well-known Harvard fruit-fly geneticist. She was absolutely fuming at Celera and the short cuts they had taken in their Drosophilia sequencing. Didn't have time to get the details, but one issue was how they had dealt with (or rather not dealt with) transposable elements. Peter P.S. Pretty nice couple of days out there in Biotechland! So much for "rate cuts are bad for biotechs."